eric topol glp-1 New @Nature A quintuple [GLP-1 + 4 other] receptor agonist drug that exceeds effects of the dual receptor (GLP-1 and GIP, tirzepatide) in the experimental model vs diabetes and obesity (in case Q&A: Dr. Eric Topol on
Pay in 4 interest-free payments of $6.95 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
![eric topol glp-1 New @Nature A quintuple [GLP-1 + 4 other] receptor agonist drug that exceeds effects of the dual receptor (GLP-1 and GIP, tirzepatide) in the experimental model vs diabetes and obesity (in case Q&A: Dr. Eric Topol on](https://substackcdn.com/image/fetch/$s_!x2MN!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fc6422889-fc19-436d-8b42-a084661851dd_1200x1200.png)
![eric topol glp-1 New @Nature A quintuple [GLP-1 + 4 other] receptor agonist drug that exceeds effects of the dual receptor (GLP-1 and GIP, tirzepatide) in the experimental model vs diabetes and obesity (in case Q&A: Dr. Eric Topol on](https://substackcdn.com/image/fetch/$s_!mcVN!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fbucketeer-e05bbc84-baa3-437e-9518-adb32be77984.s3.amazonaws.com%2Fpublic%2Fimages%2Fb9a54d0b-0c13-4fc0-8631-0b5da5e30c52_3814x3370.png)
![eric topol glp-1 New @Nature A quintuple [GLP-1 + 4 other] receptor agonist drug that exceeds effects of the dual receptor (GLP-1 and GIP, tirzepatide) in the experimental model vs diabetes and obesity (in case Q&A: Dr. Eric Topol on](https://pbs.twimg.com/media/HAvw2D9aAAMZ9Mg.jpg)
























